Haemonetics (HAE) Total Debt (2010 - 2026)

Haemonetics has reported Total Debt for 17 years, with the latest figure at $1.2 billion in Q2 2026.

• On a quarterly basis, Total Debt fell 21.95% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 21.95% decrease from a year earlier, with the FY2026 full-year figure at $1.2 billion, changed 0.02% from the prior year.
• Total Debt was $1.2 billion for Q2 2026 at Haemonetics, down from $1.2 billion in the prior quarter.
• The five-year high for Total Debt was $1.5 billion in Q4 2025, with the low at $762.2 million in Q3 2023.
• Average Total Debt over 5 years is $1.0 billion, with a median of $870.6 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Total Debt surged 150.89% in 2022, then dropped 21.95% in 2026.
• Over 5 years, Total Debt stood at $766.8 million in 2022, then rose by 13.54% to $870.6 million in 2023, then surged by 40.69% to $1.2 billion in 2024, then gained by 24.87% to $1.5 billion in 2025, then declined by 21.99% to $1.2 billion in 2026.
• The last three Total Debt figures came in at $1.2 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.